This is really important. Stuff getting publicized *without a paper* and without sufficient time for many scientists to look at, digest, comment and contextualize can lead to terrible outcomes—needlessly scaring people. We saw that happen with widely misreported studies before.https://twitter.com/EricTopol/status/1364769339434409984 …
We can talk about them the next day, after the scientific community had a chance to see the paper and digest and respond to the news. I'm not saying ignore it at all. Give it a day! The online scientific community response is really, really fast these days.
-
-
Sure I agree in this case (I didn't post the story about the 'CA variant' to my
@covidpath aggregator cause it seemed ambiguous). But I've also seen you take objection to commentary on studies about comparative efficacy etc. I do agree we are in the endgame so nobody should panic -
Those—comparing efficacy—are largely being misreported, though, that's the problem. Different issue. Otherwise, of course, fine to inform people. I'm going to write longer on why and how on that one soon.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.